The aryl hydrocarbon receptor complex

Annual Review of Pharmacology and Toxicology

Volumn 35, Issue , 1995, Pages 307-340

  Hankinson, Oliver ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AHR; ARNT; dioxin receptor; polycyclic aromatic hydrocarbons; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; DIMER; HALOGENATED ARYL HYDROCARBON; MONOMER; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

DNA BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LIGAND BINDING; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 0028987872     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pa.35.040195.001515     Document Type: Review

References (199)

1. Hahn ME, Poland A, Glover E, Stegeman JJ. 1994. Photoaffinity labeling of the Ah receptor: phylogenetic survey of diverse vertebrate and invertebrate species. Arch. Biochem. Biophys. 310:218-28
2. Savas U, Christou M, Jefcoate CR. 1993. Mouse endometrium stromal cells express a polycyclic aromatic hydrocarbon-inducible cytochrome P450 that closely resembles the novel P450 in mouse embryo fibroblasts (P450EF), Carcinogenesis 14:2013-18
3. Poland A, Knutson JC. 1982. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity, Annu. Rev. Pharmacol. Toxicol. 22:517-54
4. Swanson HI, Bradfield CA. 1993. The AH-receptor: genetics, structure and function. Pharmacogenetics 3:213-30
5. Whitlock JP Jr. 1993. Mechanistic aspects of dioxin action. Chem. Res. Toxicol. 6:754-63
6. Nebert DW, Puga A, Vasiliou V. 1993. Role of the Ah receptor and the dioxininducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. NY Acad. Sci. 685:624-40
7. Vanden Heuvel JP, Lucier G. 1993. Environmental toxicology of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans. Environ. Health Perspect. 100:189-200
8. Hines RN, Piechocki MP, Boucher PD. 1994. Molecular mechanisms controlling CYP1A gene expression. In Frontiers in Biotransformation. Vol. 9. Regulation and Control of Complex Biological Processes by Biotransfomiation. ed. K Ruckpaul, H Rein, pp. 85-110. Berlin/New York: Akademie Verlag/ VCH
9. Bock KW. 1993. Aryl hydrocarbon or dioxin receptor: biological and toxic re-spouses. Rev. Phys. Biochem. Pharmacol. 125:1-42
10. Okey AB, Riddick DS, Harper PA. 1994. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett. 70:1-22
11. Birnbaum LS. 1994. The mechanism of dioxin toxicity: relationship to risk assessment. Environ. Health Perspect. In press
12. Huffman EC, Reyes H, Chu F-F, Sander F, Conley LH, et al. 1991. Cloning of a factor required for the activity of the Ah (Dioxin) receptor. Science 252:954-58
13. Reyes H, Reisz-Porszasz S, Hankinson O. 1992. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256: 1193-95
14. Poland A, Glover E, Ebetino FH, Kende AS. 1986. Photoaffinity labeling of the Ah receptor. J. Biol. Chem. 261:6352-65
15. Bradfield CA, Glover E, Poland A. 1991. Purification and N-terminal amino acid sequence of the Ah receptor from the C57BL/6J mouse. Mol. Pharmacol. 39:13-19
16. Ema M, Sogawa K, Watanabe N, Chujoh Y, Matsushita N, et al. 1992. cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 184:246-53
17. Burbach KM, Poland A, Bradfield CA. 1992. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. USA 89:8185-89
18. Reisz-Porszasz S, Probst MR, Fukunaga BN. Hankinson O. 1994. Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT). Mol. Cell. Biol. 14: 6075-86
19. Itoh S, Kamalaki T. 1993. Human Ah receptor cDNA: analysis for highly conserved sequences. Nucleic Acids Res. 21:3578
20. Dolwick KM, Schmidt JV, Carver LA, Swanson HI, Bradfield CA. 1993. Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. 44: 911-17
21. Murre C, Baltimore D. 1992. The helixloop-helix motif: structure and function. In Transcriptional Regulation, ed. SL McKnight, KR Yamamoto, pp. 861-79. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press
22. Nambu JR, Lewis JO, Wharton KA, Crews ST. 1991. The Drosophila single-minded gene encodes a helix-loophelix protein that acts as a master regulator of CNS midline development. Cell 67:1157-67
23. Huang ZJ, Edery I, Rosbash M. 1993. PAS is a dimerization domain common to Drosophila period and several transcription factors. Nature 364:259-62
24. Johnson B, Brooks BA, Heinzmann C, Diep A, Mohandas T, et al. 1993. The Ah receptor nuclear translocator gene (ARNT) is located on q21 of human chromosome 1 and on mouse chromosome 3 near CF-3. Genomics 17:592-98
25. Le Beau MM, Carver LA, Espinosa R III, Schmidt JV, Bradfield CA. 1994. Chromosomal localization of the human AHR locus encoding the structural gene for the Ah receptor to 7p21-pl5. Cytogenet. Cell Genet. 66:172-76
26. Poland A, Glover E, Taylor BA. 1987. The murine Ah locus: a new allele and mapping to chromosome 12. Mol. Pharmacol. 32:471-78
27. Schmidt JV, Carver LA, Bradfield CA. 1993. Molecular characterization of the murine Ahr gene. Organization promoter analysis and chromosomal assignment. J. Biol. Chem. 268:22203-9
28. 1-450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically "nonresponsive" to other aromatic hydrocarbons. J. Biol. Chem. 249:5599-5606
29. 1-450 by 3-methylcholanthrene. Mol. Pharmacol. 35(6):823-30
30. Chang C-y, Smith DR, Prasad VS, Sid-man CL, Nebert DW, Puga A. 1993. Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics 3:312-21
31. Robinson JR, Considine N, Nebert DW. 1974. Genetic expression of aryl hydrocarbon hydroxylase induction. Evidence for the involvement of other genetic loci. J. Biol. Chem. 249:5851-59
32. Nakachi K, Imai K, Hayashi S-I, Kawajiri K. 1993. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 53:2994-99
33. Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Anttila S, Vainio H. 1992. Point-mutated Msp1 and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol. Biomarkers Prev. 1:485-89
34. Okey AB. 1990. Enzyme induction in the cytochrome P-450 system. Pharmacol. Ther. 45:241-98
35. Cosma G, Crofts F, Currie D, Wirgin I, Toniolo P, Garte SJ. 1993. Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene. Cancer Epidemiol. Biomarkers Prev. 2: 53-57
36. Wedlund PJ, Kimura S, Gonzalez FJ, Nebert DW. 1994. I462V mutation in the human CYP1A1 gene: lack of correlation with either the Msp I 1.9 kb (M2) allele or CYPIAI inducibility in a three-generation family of East Mediterranean descent. Pharmacogenetics 4: 21-26
37. Pohjanvirta R. 1990. TCDD resistance is inherited as an autosomal dominant trait in the rat. Toxicol. Lett. 50:49-56
38. Pohjanvirta R, Unkila M, Tuomisto J. 1993. Comparative acute lethality of 2,3, 7,8-tetrachlorodibenzo-p-dioxin (TCDD), 1,2,3,7,8-pentachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in the most TCDD-susceptible and the most TCDD-resistant rat strain. Pharmacol. Toxicol. 73:52-56
39. Hankinson O. 1979. Single-step selection of clones of a mouse hepatoma line deficient in aryl hydrocarbon hydroxylase. Proc. Natl. Acad. Sci. USA 76:373-76
40. Hankinson O. 1994. A genetic analysis of processes regulating cytochrome P4501A1 expression. Adv. Enzyme Regul. 34:159-71
41. 1-450 gene in mouse Hepa-1 cell cultures. J. Biol. Chem. 260:1790-95
42. Robertson JA, Neben DW, Hankinson O. 1987. Autoregulation plus positive and negative elements controlling transcription of genes in the [Ah] battery. Chem. Scr. 27A:83-87
43. Vasiliou V, Puga A, Nebert DW. 1992. Negative regulation of the murine cytosolic aldehyde dehydrogenase-3 (Aldh-3c) gene by functional CYP1A1 and CYP1A2 proteins. Biochem. Biophys. Res. Commun. 187:413-19
44. Legraverend C, Hannah RR, Eisen HJ, Owens IS, Neben DW, Hankinson O. 1982. Regulatory gene product of the Ah locus: characterization of receptor mutants among mouse hepatoma clones. J. Biol. Chem. 257:6502-7
45. Pollenz RS, Sattler CA. Poland A. 1994. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol. Pharmacol. 45:428-38
46. Karenlampi SO, Legraverend C, Gudas JM, Hankinson O. 1988. A third genetic locus affecting the Ah (dioxin) receptor. J. Biol. Chem. 263(21):10111-17
47. Watson AJ, Weir-Brown KI, Bannister RO, Chu F-F, Reisz-Porszasz S, et al. 1992. Mechanism of action of a represser of dioxin-dependent induction of Cyplal gene transcription. Mol. Cell. Biol. 12:2115-23
48. Miller AG, Israel DI, Whitlock JP Jr. 1983. Biochemical and genetic analysis of variant mouse hepatoma cells defective in the induction of benzo(a)pyrenemetabolizing enzyme activity. J. Biol. Chem. 258(6):3523-27
49. 1-450 gene transcription by inhibition of protein synthesis in wild type and variant mouse hepatoma cells. J. Biol. Chem. 260:5648-53
50. Cikryt P, Gottlicher M, Neumann H-G. 1990. Competitive binding affinity of carcinogenic aromatic amines to the rat hepatic aromatic hydrocarbon (Ah) receptor in vitro and potency to induce monooxygenase activity in vitro. Carcinogenesis 11:1359-66
51. Gillner M, Bergman J, Cambillau C, Gustafsson JA. 1989. Interactions of rutaecarpine alkaloids with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis 10:651-54
52. Bjeldanes LF, Kim JY, Grose KR, Bartholomew JC, Bradfield CA. 1991. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. USA 88:9543-47
53. Gillner M, Bergman J, Cambillau C, Alexandersson M, Fernstrom B, Gustafsson JA. 1993. Interactions of indolo[3,2-b]carbazoles and related polycyclic aromatic hydrocarbons with specific binding sites for 2,3,7,8-tetra-chlorodibenzo-p-dioxin in rat liver. Mol. Pharmacol. 44:336-45
54. Kafafi SA, Afeefy HY, Ali AH, Said HK, Abd-Elazem IS, Kafafi AG. 1993. Affinities for the aryl hydrocarbon receptor, potencies as aryl hydrocarbon hydroxylase inducers and relative toxicities of polychlorinated biphenyls. A congener specific approach. Carcinogenesis 14:2063-71
55. Landers JP, Bunce NJ. 1991. The Ah receptor and the mechanism of dioxin toxicity. Biochem. J. 276:273-87
56. Rannug U, Sjogren M, Rannug A, Gillner M, Toftgard R, et al. 1991. Use of artificial intelligence in structure-affinity correlations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) receptor ligands. Carcinogenesis 12:2007-15
57. Okey AB, Vella LM. 1982. Binding of 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin to a common Ah receptor site in mouse and rat hepatic cytosols. Eur. J. Biochem. 127:39-47
58. Dolwick KM, Swanson HI, Bradfield CA. 1993. In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. Proc. Natl. Acad. Sci. USA 90:8566-70
59. Whitelaw ML, Gottlicher M, Gustafsson JA, Poellinger L. 1993. Definition of a novel ligand binding domain of a nuclear bHLH receptor: co-localization of ligand and hsp90 binding activities within the regulable inactivation domain of the dioxin receptor. EMBO J. 12:4169-79
60. Denison MS, Vella LM, Okey AB. 1987. Structure and function of the Ah receptor: sulfhydryl groups required for binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to cytosolic receptor from rodent liver. Arch. Biochem. Biophys. 252:388-95
61. 125I] 2-iodo-2,8-dibromodibenzo-p-dioxin. Mol. Pharmacol. 34:229-37
62. Bunce NJ, Landers JP, Safe SH. 1988. Kinetic models for association of 2,3, 7,8-tetrachlorodibenzo-p-dioxin with the Ah receptor. Arch. Biochem. Biophys. 267:384-97
63. Berghard A, Gradin K, Toftgard R. 1992. The stability of dioxin-receptor ligands influences cytochrome P450IA1 expression in human keratinocytes. Carcinogenesis 13:651-55
64. Riddick DS, Huang Y, Harper PA, Okey AB. 1994. 2,3,7,8-tetrachlorodibenzo-p-dioxin versus 3-methylcholanthrene: comparative studies of aromatic hydrocarbon (Ah) receptor binding, transformation, and induction of CYP1A1 expression. J. Biol. Chem. 269:12118-28
65. Denison MS, Vella LM, Okey AB. 1986. Structure and function of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin: species difference in molecular properties of the receptors from mouse and rat hepatic cytosols. J. Biol. Chem. 261: 3987-95
66. Cuthill S, Poellinger L, Gustafsson J-A. 1987. The receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse hepatoma cell line Hepa 1c1c7: a comparison to the glucocorticoid receptor and the mouse and rat hepatic dioxin receptors. J. Biol. Chem. 262:3477-81
67. Perdew GH. 1992. Chemical cross-linking of the cytosolic and nuclear forms of the Ah receptor in hepatoma cell line 1c1c7. Biochem. Biophys. Res. Commun. 182:55-62
68. Perdew GH. 1988. Association of the Ah receptor with the 90-kDa heat shock protein. J. Biol. Chem. 263(27): 13802-5
69. Denis M, Cuthill S, Wikstrom AC, Poellinger L, Gustafsson J-A. 1988. Association of the dioxin receptor with the Mr 90,000 heat shock protein: a structural kinship with the glucocorticoid receptor. Biochem. Biophys. Res. Commun. 155:801-7
70. Perdew GH, Hord N, Hollenback CE, Welsh MJ. 1993. Localization and characterization of the 86-and 84-kDa heat shock proteins in Hepa 1c1c7 cells. Exp. Cell Res. 209:350-56
71. Denison MS. 1992. Heterogeneity of rat hepatic Ah receptor: identification of two receptor forms which differ in their biochemical properties. J. Biochem. Toxicol. 7:249-56
72. Pongratz I, Mason GG, Poellinger L. 1992. Dual roles of the 90-kDa heat shock protein hsp90 in modulating functional activities of the dioxin receptor. Evidence that the dioxin receptor func-tionally belongs to a subclass of nuclear receptors which require hsp90 both for ligand binding activity and repression of intrinsic DNA binding activity. J. Biol. Chem. 267:13728-34
73. Henry EC, Gasciewicz TA. 1993. Transformation of the aryl hydrocarbon receptor to a DNA-binding form is accompanied by release of the 90 kDa heat-shock protein and increased affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. J. 294:95-101
74. Probst MR, Reisz-Porszasz S, Agbunag RV, Ong MS, Hankinson O. 1993. Role of the aryl hydrocarbon (Ah) receptor nuclear translocator protein (ARNT) in aryl hydrocarbon (dioxin) receptor action. Mol. Pharmacol. 44:511-18
75. Whitelaw M, Pongratz I, Wilhelmsson A, Gustafsson JA, Poellinger L. 1993. Ligand-dependent recruitment of the Arnt coregulator determines DNA recognition by the dioxin receptor. Mol. Cell. Biol. 13:2504-14
76. Swanson HI, Perdew GH. 1993. Half-life of aryl hydrocarbon receptor in Hepa-1 cells: evidence for ligand-dependent alterations in cytosolic receptor levels. Arch. Biochem. Biophys. 302:167-74
77. Okey AB, Bondy GP, Mason ME, Nebert DW, Forster-Gibson O, et al. 1980. Temperature-dependent cytosol-to-nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dio-xin in continuous cell culture lines. J. Biol. Chem. 255:11415-22
78. 1-450mRNA. Cell 31:275-84
79. Cuthill S, Wilhelmsson A, Poellinger L. 1991. Role of the ligand in intracellular receptor function: receptor affinity determines activation in vitro of the latent dioxin receptor to a DNA-binding form. Mol. Cell. Biol. 11:401-11
80. Harper PA, Giannone JV, Okey AB, Denison MS. 1992. In vitro transformation of the human Ah receptor and its binding to a dioxin response element. Mol. Pharmacol. 42:603-12
81. Henry E, Rucci G, Gasciewicz TA. 1989. Characterization of multiple forms of the Ah receptor: comparison of species and tissues. Biochemistry 28:6430-40
82. McGuire J, Whitelaw ML, Pongratz I, Gustafsson J-A, Poellinger L. 1994. A cellular factor stimulates ligand-dependent release of hsp90 from the basic helix-loop-helix dioxin receptor. Mol. Cell. Biol. 14:2438-46
83. Wilhelmsson A, Cuthill S, Denis M, Wikstrom AC, Gustafsson JA, Poellinger L. 1990. The specific DNA binding activity of the dioxin receptor is modulated by the 90 kD heat shock protein. EMBO J. 9:69-76
84. Perdew GH. 1991. Comparison of the nuclear and cytosolic forms of the Ah receptor from Hepa 1c1c7 cells: charge heterogeneity and ATP binding properties. Arch. Biochem. Biophys. 291:284-90
85. Pratt WB. 1993. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem. 268(29):21455-58
86. Abbott BD, Perdew GH, Birnbaum LS. 1994. Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicol. Appl. Pharmocol. 126:16-25
87. Fujisawa-Sehara A, Sogawa K, Yamane M, Fujii-Kuriyama Y. 1987. Characterization of xenobiotic responsive elements upstream from the drug-metabolizing cytochrome P-450c gene: a similarity to glucocorticoid regulatory elements. Nucleic Acids Res. 15:4179-91
88. Denison MS, Fisher JM, Whitlock JP Jr. 1988. The DNA recognition site for the dioxin-Ah receptor complex. J. Biol. Chem. 263:17221-24
89. Lusska A, Shen E, Whitlock JP Jr. 1993. Protein-DNA interactions at a dioxin-responsive enhancer. Analysis of six bona-fide DNA-binding sites for liganded Ah receptor. J. Biol. Chem. 268: 6575-80
90. Shen ES, Whitlock JP Jr. 1992. Protein-DNA interactions at a dioxin-responsive enhancer. Mutational analysis of the DNA-binding site for the liganded Ah receptor. J. Biol. Chem. 267:6815-19
91. Yao EF, Denison MS. 1992. DNA sequence determinants for binding of transformed Ah receptor to a dioxin-responsive enhancer. Biochemistry 31: 5060-67
92. Shen ES, Whitlock JP Jr. 1989. The potential role of DNA methylation in the response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 264: 17754-58
93. Neuhold LA, Shirayoshi Y, Ozalo K, Jones JE, Nebert DW. 1989. Regulation of mouse CYP1A1 gene expression by dioxin: requirement of two as-acting elements during induction. Mol. Cell. Biol. 9:2378-86
94. 2+ requirement. J. Biol. Chem. 265:9251-58
95. Bank PA, Yao EF, Phelps CL, Harper PA, Denison MS. 1992. Species-specific binding of transformed Ah receptor to a dioxin responsive transcriptional enhancer. Eur. J. Pharmacol. 228:85-94
96. Watson AJ, Hankinson O. 1992. Dioxin and Ah receptor-dependent protein binding to xenobiotic responsive elements and G-rich DNA studied by in vivo footprinting. J. Biol. Chem. 266(10): 6874-78
97. Wu L, Whitlock JP Jr. 1993. Mechanism of dioxin action: receptor-enhancer interactions in intact cells. Nucleic Acids Res. 21:119-25
98. Robertson RW, Zhang L, Pasco DS, Pagan JB. 1994. Aryl hydrocarbon-induced interactions at multiple DNA elements of diverse sequence - a multi-component mechanism for activation of cytochrome P4501A1 (CYP1A1) gene transcription. Nucleic Acids Res. 22: 1741-49
99. Elferink CJ, Gasciewicz TA, Whitlock JP Jr. 1990. Protein-DNA interactions at a dioxin-responsive enhancer. Evidence that the transformed Ah receptor is heteromeric. J. Biol. Chem. 265: 20708-12
100. Swanson HI, Tullis K, Denison MS. 1993. Binding of transformed Ah receptor complex to a dioxin responsive transcriptional enhancer: evidence for two distinct heteromeric DNA-binding forms. Biochemistry 32:12841-49
101. Elferink CJ, Whitlock JP Jr. 1994. Dioxin-dependent, DNA sequence-specific binding of a multi-protein complex containing the Ah receptor. Receptor 4:157-73
102. Ferré-D'Amaré AR, Prendergast GC, Ziff EB, Burley SK. 1993. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 363:38-44
103. Ferré-D'Amaré AR, Pognonec P, Roeder RG, Burley SK. 1994. Structure and function of the b/HLH/Z domain of USF. EMBO J. 13:180-89
104. Ellenberger T, Pass D, Arnaud M, Harrison SC. 1994. Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer. Genes Dev. 8:970-80
105. Ma PCM, Rould MA, Weimraub H. Pabo CO, 1994. Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation. Cell 77:451-59
106. Dang CV, Dolde C, Gillison ML, Kato GJ. 1992. Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins. Proc. Natl. Acad. Sci. USA 89:599-602
107. 1-450 gene transcription by 2,3,7,8-tetrachlorodibenzo-p-dioxin in wild type and variant mouse hepatoma cells. J. Biol. Chem. 259:5400-2
108. 3-450 mRNA levels by 3-methylcholanthrene. Mol. Pharmacol. 26:117-21
109. Fisher JM, Jones KW, Whitlock JP Jr. 1989. Activation of transcription as a general mechanism of 2,3,7,8-tetra-chlorodibenzo-p-dioxin action. Mol. Carcinog. 1:216-21
110. Fisher JM, Wu L, Denison MS, Whitlock JP Jr. 1990. Organization and function of a dioxin-responsive enhancer. J. Biol. Chem. 265:9676-81
111. Morgan JE, Whitlock JP Jr. 1992. Transcription-dependent and transcription-independent nucleosome disruption induced by dioxin. Proc. Natl. Acad. Sci. USA 89:11622-26
112. Gradin K, Wilhelmsson A, Poellinger L, Berghard A. 1993. Nonresponsiveness of normal human fibroblasts to dioxin correlates with the presence of a constitutive xenobiotic response element-binding factor. J. Biol. Chem. 268: 4061-68
113. McGhee JD, Felsenfeld G. 1979. Reaction of nucleosome DNA with dimethyl sulfate. Proc. Natl. Acad. Sci. USA 76: 2133-37
114. Hapgood J, Cuthill S, Soderkvist P, Wilhelmsson A, Pongratz I, et al. 1991. Liver cells contain constitutive DNase I-hypersensitive sites at the xenobiotic response elements 1 and 2 (XRE1 and -2) of the rat cytochrome P-450IA1 gene and a constitutive, nuclear XRE-binding factor that is distinct from the dioxin receptor. Mol. Cell. Biol. 11:4314-23
115. Jones KW, Whitlock JP Jr. 1990. Functional analysis of the transcriptional promoter for the CYP1A1 gene. Mol. Cell. Biol. 10:5098-5105
116. Imataka H, Sogawa K, Yasumoto K, Kikuchi Y, Sasano K, et al. 1992. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. EMBO J. 11(10): 3663-71
117. Yanagida A, Sogawa K, Yasumoto K-I, Fujii-Kuriyama Y. 1990. A novel cis-acting DNA clement required for a high level of inducible expression of the rat P-450c gene. Mol. Cell. Biol. 10(4): 1470-75
118. Wu L, Whitlock JP Jr. 1992. Mechanism of dioxin action: Ah receptor-mediated increase in promoter accessibility in vivo. Proc. Natl. Acad. Sci. USA 89: 4811-15
119. Elferink CJ, Whitlock JP Jr. 1990. 2,3, 7,8-tetrachlorodibenzo-p-dioxin-inducible, Ah receptor-mediated bending of enhancer DNA. J. Biol. Chem. 265:5718-21
120. Grunstein M. 1992. Histones as regulators of genes. Sci. Am. 267:68-74
121. Archer TK, Lefebvre P, Wolford RG, Hager GL. 1992. Transcription factor loading on the MMTV promoter: a bi-modal mechanism for promoter activation. Science 255:1573-76
122. Latchman DS. 1991. Eukaryotic Transcription Factors. San Diego: Academic/Harcourt Brace Jovanovich. 270 pp.
123. Lusska A, Wu L, Whitlock JP Jr. 1992. Superinduction of CYP1A1 transcription by cycloheximide. Role of the DNA binding site for the liganded Ah receptor. J. Biol. Chem. 267:15146-51
124. Reick M, Robertson RW, Pasco DS, Pagan JB. 1994. Down-regulation of nuclear AH receptor DNA-binding and transactivation functions-requirement for a labile or inducible factor. Mol. Cell. Biol. 14:5653-60
125. Carrier F, Owens RA, Nebert DW, Puga A. 1992. Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol. Cell. Biol. 12(4): 1856-63
126. Okino ST, Pendurthi UR, Tukey RH. 1992. Phorbol esters inhibit the dioxin receptor mediated transcriptional activation of the mouse Cyp1a-1 and Cyp1a-2 genes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 267(10):6991-98
127. Berghard A, Gradin K, Pongratz I, Whitelaw M, Poellinger L. 1993. Cross-coupling of signal transduction path-ways: the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism. Mol. Cell. Biol. 13: 677-89
128. Pongratz I, Stroemstedt P-E, Mason GF, Poellinger L. 1991. Inhibition of the specific DNA-binding activity of the dioxin receptor by phosphatase treatment. J. Biol. Chem. 266(25): 16813-17
129. Denison MS, Vella LM, Okey AB. 1989. Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver: lack of sensitivity to alkaline phosphatase when compared with that of glucocorticoid receptor. Arch. Biochem. Biophys. 273: 458-65
130. Schafer MW, Madhukar BV, Swanson HI, Tullis K, Denison MS. 1993. Protein kinase C is not involved in Ah receptor transformation and DNA binding. Arch. Biochem. Biophys. 307:267-71
131. Quattrochi LC, Vu T, Tukey RH. 1994. The human CYP1A2 gene and induction by 3-methylcholanthrene. J. Biol. Chem. 269:6949-54
132. Nguyen T, Rushmore TH, Pickett CB. 1994. Transcriptional regulation of a rat liver glutathione S-transferase Ya sub-unit gene. J. Biol. Chem. 269:13656-62
133. Nebert DW, Jensen NM, Perry JW, Oka T. 1980. Association between ornithine decarboxylase induction and the Ah locus in mice treated with polycyclic aromatic compounds. J. Biol. Chem. 255:6836-42
134. Korza G, Ozols J. 1988. Complete covalent structure of 60-kDa esterase isolated from 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced rabbit liver microsomes. J. Biol. Chem. 263:3486-95
135. Roth W, Voorman R, Aust SD. 1988. Activity of thyroid hormone-inducible enzymes following treatment with 2,3, 7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 92:65-74
136. Abbott BD, Harris MW, Birnbaum LS. 1992. Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate. Teratology 45:35-53
137. Sutter TR, Guzman K, Dold KM, Greenlee WF. 1991. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 β. Science 254: 415-18
138. Puhvel SM, Ertl DC, Lynberg CA. 1984. Increased epidermal transglutaminase activity following 2,3,7,8-tetrachlorodibenzo-p-dioxin: In vivo and in vitro studies with mouse skin. Toxicol. Appl. Pharmacol. 73:42-47
139. Bombick DW, Madhukar BV, Brewster DW, Matsumura F. 1985. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes increases in protein kinases particularly protein kinase C in the hepatic plasma membrane of the rat and the guinea pig. Biochem. Biophys. Res. Commun. 127:296-302
140. Wolfle D, Schmutte C, Marquardt H. 1993. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on protein kinase C and inositol phosphate metabolism in primary cultures of rat hepatocytes. Carcinogenesis 14:2283-87
141. Bombick DW, Jankun J, Tullis K, Matsumura F. 1988, 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains. Proc. Natl. Acad. Sci. USA 85: 4128-32
142. 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J. Biol. Chem. 267: 24591-95
143. Puga A, Nebert DW, Carrier F. 1992. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol. 11(4):269-81
144. Enan E, Matsumura F. 1994. Significance of TCDD-induced changes in protein phosphorylation in the adipocyte of male guinea pigs. J. Biochem. Toxicol. 9:159-70
145. 144a. Kurl RN, DePetrillo PB, Olnes MJ. 1993. Inhibition of Ah (dioxin) receptor transformation by 9-hydroxy-ellipticine. Biochem. Pharm. 46:1425-33
146. Daujat M, Peryt B, Lesca P, Fourtanier G, Domergue J, Maurel P. 1992. Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor. Biochem. Biophys. Res. Commun. 188:820-25
147. Houser WH, Raha A, Vickers M. 1992. Induction of CYP1A1 gene expression in H4-II-E rat hepatoma cells by benzo(e)pyrene. Mol. Carcinog. 5:232-37
148. Puga A, Raychaudhuri B, Nebert DW. 1992. Transcriptional derepression of the murine Cyp1a-1 gene by mevinolin. FASEB J. 6:777-85
149. 147a. Lewandowski M, Chui YC, Levi PE, Hodgson E. 1990. Differences in induction of hepatic cytochrome P450 isozymes by mice in eight methyl-enedioxyphenyl compounds. J. Biochem. Toxicol. 5:47-55
150. Quattrochi LC, Tukey RH. 1993. Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene. Mol. Pharmacol. 43:504-8
151. Lin FH, Stohs SJ, Birnbaum LS, Clark G, Lucier GW, Goldstein JA. 1991. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah non-responsive C57BL/6J mice. Toxicol. Appl. Pharmacol. 108:129-39
152. Harris M, Zacharewski T, Safe S. 1990. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 human breast cancer cells. Cancer Res. 50:3579-84
153. Zacharewski T, Harris M, Safe S. 1991. Evidence for the mechanism of action of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decrease of nuclear estrogen receptor levels in wild-type and mutant mouse Hepa 1c1c7 cells. Biochem. Pharmacol. 41:1931-39
154. Wang X, Porter W, Krishnan V, Narasimhan TR, Safe S. 1993. Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells. Mol. Cell. Endocrinol. 96:159-66
155. Zacharewski TR, Bondy KL, McDonnell P, Wu ZF. 1994. Anti-estrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res. 54: 2707-13
156. Clark GC, Taylor MJ, Tritscher AM, Lucier GW. 1991. Tumor necrosis factor involvement in 2,3,7,8-tetrachlorodibenzo-p-dioxin-medialed endotoxin hypersensitivity in C57BL/6J mice congenic at the Ah locus. Toxicol. Appl. Pharmacol. 111:422-31
157. Ma X, Mufti NA, Babish JG. 1992. Protein tyrosine phosphorylation as an indicator of 2,3,7,8-tetrachloro-p-dioxin exposure in vivo and in vitro. Biochem. Biophys. Res. Commun. 189:59-65
158. Ma X, Babish JG. 1993. Acute 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure results in enhanced tyrosylphosphorylation and expression of murine hepatic cyclin dependent kinases. Biochem. Biophys. Res. Commun. 197:1070-77
159. Enan E, Liu PC, Matsumura F. 1992. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes reduction of glucose transporting activities in the plasma membranes of adipose tissue and pancreas from the guinea pig. J. Biol. Chem. 267:19785-91
160. Poland A, Glover E. 1980. 2,3,7,8-tetrachlorodibenzo-p-dioxin: segregation of toxicity with the Ah locus. Mol. Pharmacol. 17:86-94
161. Couture LA, Abbott BD, Birnbaum LS. 1990. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism. Teratology 42:619-27
162. Taylor MJ, Lucier GW, Mahler JF, Thompson M, Lockhart AC, Clark GC. 1992. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor
163. Rozman K, Rozman T, Greim H. 1984. Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity. Toxicol. Appl. Pharmacol. 72:372-76
164. Knutson JC, Poland A. 1982. Response of murine epidermis to 2,3,7,8-tetrachlorodibenzo-p-dioxin: interaction of the Ah and hr loci. Cell 30:225-34
165. Peterson RE, Theobald HM, Kimmel GL. 1993. Developmental and reproductive toxicity of dioxins and related compounds: cross-species comparisons. Crit. Rev. Toxicol. 23:283-335
166. Huff J, Lucier G, Tritscher A. 1994. Carcinogenicity of TCDD: experimental, mechanistic, and epidemiologic evidence. Annu. Rev. Pharmacol. Toxicol. 34:343-72
167. Sternberg SS. 1994. Is dioxin a human carcinogen? (continued). Science 263: 1545-46
168. Shu HP, Paustenbach DJ, Murray FJ. 1987. A critical evaluation of the use of mutagenesis, carcinogenesis, and tumor promotion data in a cancer risk assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Regul. Toxicol. Pharmacol. 7:57-88
169. Clark G, Tritscher A, Maronpot R, Foley J, Lucier G. 1991. Tumor promotion by TCDD in female rats. In Banbury Report. Biological Basis for Risk Assessment of Dioxins and Related Compounds, 35:389-404. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press
170. Poland A, Glover E, Bradfield CA. 1990. Characterization of polyclonal antibodies to the Ah receptor prepared by immunization with a synthetic peptide hapten. Mol. Pharmacol. 39:20-26 [erratum 1991. Mol. Pharmacol. 39(4):435]
171. Hayashi S-i, Watanabe J, Nakachi K, Eguchi H, Gotoh O, Kawajiri K. 1994. Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15:801-6
172. 169a. Carver LA, Hogenesch JB, Bradfield CA. 1994. Tissue specific expression of the rat Ah-receptor and ARNT mRNAs. Nucl. Acids Res. 22:3038-44
173. Okey AB, Vella LM. 1984. Elevated binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene to the Ah receptor in hepatic cytosols from phenobarbital-treated rats and mice. Biochem. Pharmacol. 33:531-38
174. Benedetti L, MacCormack LS, Bunce NJ. 1994. Characterization of a phenobarbital-inducible Ah receptor-like protein in the Sprague-Dawley rat. Arch. Biochem. Biophys. 309:1-9
175. Gottlicher M, Cikryt P. 1987. Induction of the aromatic hydrocarbon receptor by trans-4-acetylaminostilbene in rat liver. Comparison with other aromatic amines. Carcinogenesis 8:1021-23
176. Sloop TC, Lucier GW. 1987. Dose-dependent elevation of Ah receptor binding by TCDD in rat liver. Toxicol. Appl. Pharmacol. 88:329-37
177. Harris M, Zacharewski T, Astroff B, Safe S. 1989. Partial antagonism of 2,3, 7,8 -tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies. Mol. Pharmacol 35:729-35
178. Prokipcak RD, Okey AB. 1991. Down-regulation of the Ah receptor in mouse hepatoma cells treated in culture with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Can. J. Physiol. Pharmacol. 69:1204-10
179. Greenlee WF, Skopek TR, Gaido K, Walker C. 1990. Comparative genetic mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced tumors. Prog. Clin. Biol. Res. 331:177-86
180. Wen L-P, Koeiman N, Whitlock JP Jr. 1990. Dioxin-inducible, Ah receptor-dependent transcription in vitro. Proc. Natl. Acad. Sci. USA 87:8545-49
181. Abernethy DJ, Greenlee WF, Huband JC, Boreiko CJ. 1985. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) promotes the transformation of C3H/10T1/2 cells. Carcinogenesis 6:651-53
182. Tanaka N, Nettesheim P, Gray T, Nelson K, Barren JC. 1989. 2,3,7,8-tetrachlorodibenzo-p-dioxin enhancement of N-methyl-N'-nitro-N-nitroso-guanidine-induced transformation of rat tracheal epithelial cells in culture. Cancer Res. 49:2703-8
183. Greenlee WF, Osborne R, Dold KM, Hudson LG, Young MJ, Toscano WA Jr. 1987. Altered regulation of epidermal cell proliferation and differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In Reviews in Biochemical Toxicology, ed. E Hodgson, J Bend, RM Philpot, 8:1-35. New York: Elsevier/ North-Holland
184. Matsumura F. 1994. How important is the protein phosphorylation pathway in the toxic expression of dioxin-type Chemicals? Biochem. Pharmacol. 48: 215-24
185. 1-450 induction by use of a cloned DNA sequence. J. Biol. Chem. 256(13):6969-74
186. Pasco DS, Boyum KW, Elbi C, Siu CS, Fagan JB. 1993. Inducer-dependent transcriptional activation of the P4501A2 gene in vivo and in isolated hepatocytes. J. Biol. Chem. 268(2): 1053-57
187. Sutter TR, Tang YM, Hayes CL, Wo Y-YP, Jabs EW, et al. 1994. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 269: 13092-99
188. Favreau LV, Pickelt CB. 1991. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J. Biol. Chem. 266:4556-61
189. Teeter LD, Petersen DD, Nebert DW, Kuo MT. 1991. Murine mdr-1, mdr-2, and mdr-3 gene expression: no coinduction with the Cypla-1 and Nmo-1 genes in liver by 2,3,7,8-tetrachlorodibenzo-p-dioxin. DNA Cell Biol. 10:433-41
190. Rushmore TH, Pickett CB. 1991. Xenobiotic responsive elements controlling inducible expression by planar aromatic compounds and phenolic antioxidants. Methods Enzymol. 206:409-20
191. Greenlee WF, Sutter TR, Marcus C. 1994. Molecular basis of dioxin actions on rodent and human target tissues. Prog. Clin. Biol. Res. In press
192. Poland A, Glover E. 1973. Chlorinated dibenzo-p-dioxins: potent inducers of δ-aminolevulinic acid synthetase and aryl hydrocarbon hydroxylase. Mol. Pharmacol. 9:736-47
193. Takimoto K, Lindahl R, Pilot HC. 1991. Superinduction of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of aldehyde dehydrogenase by the inhibition of protein synthesis. Biochem. Biophys. Res. Commun. 180:953-59
194. Takimoto K, Lindahl R, Pilot HC. 1992. Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of aldehyde dehydrogenase in hepatoma cells. Arch. Biochem. Biophys. 298:493-97
195. Chen H-S, Perdew GH. 1994. Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. J. Biol. Chem. 269:27554-58
196. Whitelaw ML, Gustafsson J-A, Poellinger L. 1994. Identification of transactivation and repression functions of the dioxin receptor and its basic helix-loop-helix/PAS partner factor Arnt: inducible versus constitutive modes of regulation. Mol. Cell. Biol. 14:8343-55
197. Li H, Dong L, Whitlock JP. 1994. Transcriptional activation function of the mouse Ah receptor nuclear translocator. J. Biol. Chem. 269:28098-105
198. Ema M, Ohe N, Suzuki M, Mimura J, Sogawa K, Ikawa S, Fujii-Kuriyama Y. 1994. Dioxin binding activities of polymorphic forms of mouse and human aryl hydrocarbon receptors. J. Biol. Chem. 269:27337-43
199. Gradin K, Whitelaw ML, Tofgard R, Poellinger L, Berghard A. 1994. A tyrosine kinase-dependent pathway regulates ligand-dependent activation of the dioxin receptor in human keratinocytes. J. Biol. Chem. 269:23800-7